Additionally, therapeutic strategies targeting MMP-2 activity, such as the use of specific inhibitors, may offer new avenues for managing and mitigating vascular and cardiac complications in patients with RH and patients with cardiovascular disease as in our prior study [34]. Here, MMP2 is linked to cardiovascular disorder.